Reproductive Health Outcomes of Insured Adolescent and Adult Women Who Access Oral Levonorgestrel Emergency Contraception

OBJECTIVE:: To assess the level of risk for adolescents and women who seek emergency contraception through various clinical routes and the opportunities for improved care provision. METHODS:: This study looked at a retrospective cohort to assess contraception and other reproductive health outcomes among adolescents and women aged 15-44 years who accessed oral levonorgestrel emergency contraception through an office visit or the call center at Kaiser Permanente Northern California from 2010 to 2011. RESULTS:: Of 21421 prescriptions 14531 (67.8%) were accessed through the call center. In the subsequent 12 months 12127 (56.6%) adolescents and women had short-acting contraception (pills patches rings depot medroxyprogesterone) dispensed and 2264 (10.6%) initiated very effective contraception (intrauterine contraception implants sterilization). Initiation of very effective contraception was similar for adolescents and women who accessed it through the call center-1569 (10.8%) and office visits-695 (10.1%) (adjusted odds ratio [OR] 1.02 95% confidence interval [CI] 0.93-1.13). In the subsequent 6 months 2056 (9.6%) adolescents and women became pregnant. Adolescents and women who accessed emergency contraception through the call center were less likely to become pregnant within 3 months of accessing emergency contraception than woman who accessed it through office visits (adjusted OR 0.82 95% CI 0.72-0.94); however they were more likely to become pregnant within 4-6 months (adjusted OR 1.37 95% CI 1.16-1.60). Among adolescents and women who were tested for chlamydia and gonorrhea 689 (7.8%) and 928 (7.9%) were positive in the 12 months before and after accessing emergency contraception respectively. CONCLUSION:: Protocols to routinely address unmet needs for contraception at every call for emergency contraception and all office visits including visits with primary care providers should be investigated. LEVEL OF EVIDENCE:: II.